Northern Health

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma4 trials
• Coronary artery disease1 trial
• Diffuse large B-cell lymphoma1 trial

Phase

• Phase 2/34 trials
• Phase 31 trial

Status

• Recruiting4 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Monash University4 trials
• Nordic Lymphoma Group1 trial
• Population Health Research Institute1 trial

Running trials

• Recruiting

  Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Starting Immunoglobulin (Start Ig)

  NCT07202078· Phase 2/3· Monash University· Source

  Contact: Rachel Cooke, PhD

• Recruiting

  Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)

  NCT07202052· Phase 2/3· Monash University· Source

  Contact: Rachel Cooke, PhD

• Recruiting

  Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)

  NCT07202091· Phase 2/3· Monash University· Source

  Contact: Rachel Cooke, PhD

• Recruiting

  Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)

  NCT07202065· Phase 2/3· Monash University· Source

  Contact: Rachel Cooke, PhD

• Active, not recruiting

  Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

  NCT05701358· Population Health Research Institute· Source

• Recruiting

  A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

  NCT04332822· Phase 3· Nordic Lymphoma Group· Source

  Contact: Teresa Leung

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma4 recruiting
• Diffuse large B-cell lymphoma1 recruiting